Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Our e-services for applications, projects and assessments close on Thursday 24 September at 4:30pm because of system upgrades. We expect to open them again on Friday 25 September at 8am the latest.

Phantom-Based Validation and Optimization of NEOWAVE, an Innovative Cardiac Therapy Device

Reference number
Coordinator CSW Therapeutics AB
Funding from Vinnova SEK 500 000
Project duration November 2025 - July 2026
Status Completed
Venture Innovative Startups
Call Innovative Startups 2025

Important results from the project

The main goals were largely achieved. A functional tissue-mimicking phantom with embedded sensors was developed and used to assess acoustic fields, coupling, positioning, and thermal safety. Further optimization is needed for repeatable manufacturing and coupling detection. The project also strengthened international collaborations and contributed knowledge toward a potential patent.

Expected long term effects

The project provides a foundation for safer, more reliable testing, calibration, and continued development of NEOWAVE. The knowledge may also support future regulatory submissions, clinical applications, and other ultrasound or shockwave technologies.

Approach and implementation

The project covered requirements, prototype development, and testing. Technical and clinical experts supported the planning. Several design and casting iterations were required because sensor integration was more difficult than expected. Despite some delays, testing began within the project period, and collaboration with external partners worked well.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 21 August 2026

Reference number 2025-02452